86 related articles for article (PubMed ID: 22788858)
21. Association between health insurance coverage of office visit and cancer screening among women.
Friedman C; Ahmed F; Franks A; Weatherup T; Manning M; Vance A; Thompson BL
Med Care; 2002 Nov; 40(11):1060-7. PubMed ID: 12409851
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer screening among elderly urban women in a primary care setting.
Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
[TBL] [Abstract][Full Text] [Related]
23. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town.
Batra P; Kuhn L; Denny L
S Afr Med J; 2010 Jan; 100(1):39-44. PubMed ID: 20429487
[TBL] [Abstract][Full Text] [Related]
24. Pap screening in a U.S. health plan.
Insinga RP; Glass AG; Rush BB
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
[TBL] [Abstract][Full Text] [Related]
25. Determinants of utilization of papanicolaou smear among outpatient clinic attendees in north-eastern Nigeria.
Bukar M; Takai IU; Audu BM
Afr J Med Med Sci; 2012 Jun; 41(2):183-9. PubMed ID: 23185917
[TBL] [Abstract][Full Text] [Related]
26. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
[TBL] [Abstract][Full Text] [Related]
27. Use of and attitudes and knowledge about pap smears among women in Kuwait.
El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
[TBL] [Abstract][Full Text] [Related]
28. Improving follow-up after an abnormal pap smear: results from a quasi-experimental intervention study.
Kaplan CP; Bastani R; Belin TR; Marcus A; Nasseri K; Hu MY
J Womens Health Gend Based Med; 2000 Sep; 9(7):779-90. PubMed ID: 11025870
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
[TBL] [Abstract][Full Text] [Related]
30. Breast and cervical cancer screening in obese minority women.
Ferrante JM; Chen PH; Jacobs A
J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
32. Follow-up for cervical abnormalities in a managed care plan, 1999-2004.
Benard VB; Berkman ND; Kuo T; Martin CK; Richardson LC
Prev Med; 2010; 50(1-2):81-5. PubMed ID: 19932710
[TBL] [Abstract][Full Text] [Related]
33. Family planning provider referral, facilitation behavior, and patient follow-up for abnormal Pap smears.
Felix HC; Bronstein J; Bursac Z; Stewart MK; Foushee HR; Klapow J
Public Health Rep; 2009; 124(5):733-44. PubMed ID: 19753952
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization.
Roy AN; Smith M
Sleep Med; 2010 May; 11(5):462-9. PubMed ID: 20363670
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and Geographic Variations of Polypharmacy Among West Virginia Medicaid Beneficiaries.
Feng X; Tan X; Riley B; Zheng T; Bias TK; Becker JB; Sambamoorthi U
Ann Pharmacother; 2017 Nov; 51(11):981-989. PubMed ID: 28635299
[TBL] [Abstract][Full Text] [Related]
36. Co-payment policies and breast and cervical cancer screening in Medicaid.
Sabik LM; Vichare AM; Dahman B; Bradley CJ
Am J Manag Care; 2020 Feb; 26(2):69-74. PubMed ID: 32059094
[TBL] [Abstract][Full Text] [Related]
37. Association of Medicaid enrollee characteristics and primary care utilization with cancer outcomes for the period spanning Medicaid expansion in New Jersey.
Tsui J; DeLia D; Stroup AM; Nova J; Kulkarni A; Ferrante JM; Cantor JC
Cancer; 2019 Apr; 125(8):1330-1340. PubMed ID: 30561793
[TBL] [Abstract][Full Text] [Related]
38. The impact of referral to a primary physician on cervical cancer screening.
Gill JM; McClellan SA
Am J Public Health; 2001 Mar; 91(3):451-4. PubMed ID: 11236413
[TBL] [Abstract][Full Text] [Related]
39. Screening for Sexually Transmitted Infections After Cervical Cancer Screening Guideline and Medicaid Policy Changes: A Population-based Analysis.
Parekh N; Donohue JM; Corbelli J; Men A; Kelley D; Jarlenski M
Med Care; 2018 Jul; 56(7):561-568. PubMed ID: 29781922
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Continuity of Care on Cervical Cancer Screening: How Visit Pattern Affects Guideline Concordance.
Li T; Yoon J; Luck J; Bui LN; Harvey M
J Cancer Educ; 2022 Feb; 37(1):30-36. PubMed ID: 32542438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
